Cargando…

Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil

OBJECTIVE: To validate the Pulmonary Embolism Severity Index (PESI), which was developed for risk stratification after acute pulmonary embolism (PE), for use in Brazil. METHODS: This was a single-center retrospective study involving patients admitted to the emergency department with acute PE. The or...

Descripción completa

Detalles Bibliográficos
Autores principales: Soriano, Leonardo de Araujo, Castro, Talita Tavares, Vilalva, Kelvin, Borges, Marcos de Carvalho, Pazin-Filho, Antonio, Miranda, Carlos Henrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534413/
https://www.ncbi.nlm.nih.gov/pubmed/30810642
http://dx.doi.org/10.1590/1806-3713/e20170251
_version_ 1783421415689551872
author Soriano, Leonardo de Araujo
Castro, Talita Tavares
Vilalva, Kelvin
Borges, Marcos de Carvalho
Pazin-Filho, Antonio
Miranda, Carlos Henrique
author_facet Soriano, Leonardo de Araujo
Castro, Talita Tavares
Vilalva, Kelvin
Borges, Marcos de Carvalho
Pazin-Filho, Antonio
Miranda, Carlos Henrique
author_sort Soriano, Leonardo de Araujo
collection PubMed
description OBJECTIVE: To validate the Pulmonary Embolism Severity Index (PESI), which was developed for risk stratification after acute pulmonary embolism (PE), for use in Brazil. METHODS: This was a single-center retrospective study involving patients admitted to the emergency department with acute PE. The original and simplified versions of the PESI were calculated using hospital admission data from medical records. The outcome measure was the overall 30-day mortality rate. RESULTS: We included 123 patients. The mean age was 57 ± 17 years, and there was a predominance of females, who accounted for 60% of the cohort. There were 28 deaths, translating to an overall 30-day mortality rate of 23%. In the cluster analysis by risk class, overall 30-day mortality was 2.40% for classes I-II, compared with 20.00% for classes III-IV-V (relative risk [RR] = 5.9; 95% CI: 1.88-18.51; p = 0.0002). When we calculated overall 30-day mortality using the simplified version (0 points vs. ≥ 1 point), we found it to be 3.25% for 0 points and 19.51% for ≥ 1 point (RR = 2.38; 95% CI: 0.89-6.38; p = 0.06). Using the original version, a survival analysis showed that risk classes I and II presented similar Kaplan-Meier curves (p = 0.59), as did risk classes III, IV, and V (p = 0.25). However, the curve of the clusters based on the original version, showed significantly higher mortality in the III-IV-V classes than in the I-II classes (RR = 7.63; 95% CI: 2.29-25.21; p = 0.0001). The cluster analysis based on the original version showed a greater area under the ROC curve than did the analysis based on the simplified version (0.70; 95% CI: 0.62-0.77 vs. 0.60; 95% CI: 0.51-0.67; p = 0.05). CONCLUSIONS: The PESI adequately predicted the prognosis after acute PE in this sample of the population of Brazil. The cluster analysis based on the original version is the most appropriate analysis in this setting.
format Online
Article
Text
id pubmed-6534413
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Sociedade Brasileira de Pneumologia e Tisiologia
record_format MEDLINE/PubMed
spelling pubmed-65344132019-06-12 Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil Soriano, Leonardo de Araujo Castro, Talita Tavares Vilalva, Kelvin Borges, Marcos de Carvalho Pazin-Filho, Antonio Miranda, Carlos Henrique J Bras Pneumol Original Article OBJECTIVE: To validate the Pulmonary Embolism Severity Index (PESI), which was developed for risk stratification after acute pulmonary embolism (PE), for use in Brazil. METHODS: This was a single-center retrospective study involving patients admitted to the emergency department with acute PE. The original and simplified versions of the PESI were calculated using hospital admission data from medical records. The outcome measure was the overall 30-day mortality rate. RESULTS: We included 123 patients. The mean age was 57 ± 17 years, and there was a predominance of females, who accounted for 60% of the cohort. There were 28 deaths, translating to an overall 30-day mortality rate of 23%. In the cluster analysis by risk class, overall 30-day mortality was 2.40% for classes I-II, compared with 20.00% for classes III-IV-V (relative risk [RR] = 5.9; 95% CI: 1.88-18.51; p = 0.0002). When we calculated overall 30-day mortality using the simplified version (0 points vs. ≥ 1 point), we found it to be 3.25% for 0 points and 19.51% for ≥ 1 point (RR = 2.38; 95% CI: 0.89-6.38; p = 0.06). Using the original version, a survival analysis showed that risk classes I and II presented similar Kaplan-Meier curves (p = 0.59), as did risk classes III, IV, and V (p = 0.25). However, the curve of the clusters based on the original version, showed significantly higher mortality in the III-IV-V classes than in the I-II classes (RR = 7.63; 95% CI: 2.29-25.21; p = 0.0001). The cluster analysis based on the original version showed a greater area under the ROC curve than did the analysis based on the simplified version (0.70; 95% CI: 0.62-0.77 vs. 0.60; 95% CI: 0.51-0.67; p = 0.05). CONCLUSIONS: The PESI adequately predicted the prognosis after acute PE in this sample of the population of Brazil. The cluster analysis based on the original version is the most appropriate analysis in this setting. Sociedade Brasileira de Pneumologia e Tisiologia 2019 /pmc/articles/PMC6534413/ /pubmed/30810642 http://dx.doi.org/10.1590/1806-3713/e20170251 Text en © 2019 Sociedade Brasileira de Pneumologia e Tisiologia https://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Original Article
Soriano, Leonardo de Araujo
Castro, Talita Tavares
Vilalva, Kelvin
Borges, Marcos de Carvalho
Pazin-Filho, Antonio
Miranda, Carlos Henrique
Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil
title Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil
title_full Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil
title_fullStr Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil
title_full_unstemmed Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil
title_short Validation of the Pulmonary Embolism Severity Index for risk stratification after acute pulmonary embolism in a cohort of patients in Brazil
title_sort validation of the pulmonary embolism severity index for risk stratification after acute pulmonary embolism in a cohort of patients in brazil
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534413/
https://www.ncbi.nlm.nih.gov/pubmed/30810642
http://dx.doi.org/10.1590/1806-3713/e20170251
work_keys_str_mv AT sorianoleonardodearaujo validationofthepulmonaryembolismseverityindexforriskstratificationafteracutepulmonaryembolisminacohortofpatientsinbrazil
AT castrotalitatavares validationofthepulmonaryembolismseverityindexforriskstratificationafteracutepulmonaryembolisminacohortofpatientsinbrazil
AT vilalvakelvin validationofthepulmonaryembolismseverityindexforriskstratificationafteracutepulmonaryembolisminacohortofpatientsinbrazil
AT borgesmarcosdecarvalho validationofthepulmonaryembolismseverityindexforriskstratificationafteracutepulmonaryembolisminacohortofpatientsinbrazil
AT pazinfilhoantonio validationofthepulmonaryembolismseverityindexforriskstratificationafteracutepulmonaryembolisminacohortofpatientsinbrazil
AT mirandacarloshenrique validationofthepulmonaryembolismseverityindexforriskstratificationafteracutepulmonaryembolisminacohortofpatientsinbrazil